PFNX - Pfenex: Update; Still A Buy For Their Therapeutic Proteins Platform
The company
Pfenex (PFNX) is a 'development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology to develop and improve protein therapies for unmet patient needs.'
The company has made great progress since my first article, entitled 'Pfenex: A Buy for Their Therapeutic Proteins Platform', in May 2018.
Here are some examples (the list is not complete) since that time:
(Source: Company Website; Bold added for emphasis)
The stock
Given the stream of positive material news, it is perhaps no surprise that the stock has appreciated considerably in the